Reblozyl drug belongs to the group of drugs related to blood diseases with the main ingredient including Luspatercept 25mg, which is made in the form of an infusion solution. The drug is indicated in the treatment of beta thalassemia requiring frequent red blood cell transfusions, which help red blood cells mature. Therefore, before using Reblozyl, patients should carefully learn about the drug and follow the doctor's instructions.